ProfileGDS4718 / 221731_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 74% 90% 47% 75% 71% 85% 66% 78% 68% 68% 66% 80% 84% 75% 79% 71% 90% 71% 95% 71% 77% 68% 75% 73% 89% 78% 89% 58% 54% 54% 92% 79% 61% 94% 90% 52% 87% 65% 93% 72% 76% 98% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3237263
GSM549102patient 115, normal, homogenized [OPG study]7.1518374
GSM549104patient 119, normal, homogenized [OPG study]9.1603290
GSM549108patient 138, normal, homogenized [OPG study]5.3768847
GSM549119patient 077, normal, homogenized [OPG study]7.3087275
GSM549133patient 032, cancer, homogenized [OPG study]7.0558371
GSM549139patient 042, cancer, homogenized [OPG study]8.4513985
GSM549099patient 107, normal, homogenized [OPG study]6.5263766
GSM549109patient 139, normal, homogenized [OPG study]7.6227978
GSM549110patient 046, normal, homogenized [OPG study]6.714368
GSM549114patient 063, normal, homogenized [OPG study]6.7122568
GSM549122patient 082, normal, homogenized [OPG study]6.5862766
GSM549134patient 033, cancer, homogenized [OPG study]7.897380
GSM549136patient 036, cancer, homogenized [OPG study]8.4103984
GSM549140patient 044, cancer, homogenized [OPG study]7.4643175
GSM549111patient 047, normal, homogenized [OPG study]7.7686879
GSM549113patient 057, normal, homogenized [OPG study]6.9647571
GSM549132patient 031, cancer, homogenized [OPG study]9.1742490
GSM549137patient 038, cancer, homogenized [OPG study]6.9768371
GSM549142patient 047, cancer, homogenized [OPG study]9.7616895
GSM549100patient 110, normal, homogenized [OPG study]6.8857371
GSM549107patient 135, normal, homogenized [OPG study]7.577577
GSM549115patient 068, normal, homogenized [OPG study]6.6923668
GSM549116patient 072, normal, homogenized [OPG study]7.3806675
GSM549120patient 078, normal, homogenized [OPG study]7.1052873
GSM549131patient 030, cancer, homogenized [OPG study]9.0578989
GSM549118patient 074, normal, homogenized [OPG study]7.7038678
GSM549129patient 027, cancer, homogenized [OPG study]8.9600689
GSM549123patient 088, normal, homogenized [OPG study]5.9912858
GSM549124patient 006, cancer, homogenized [OPG study]5.7426454
GSM549126patient 015, cancer, homogenized [OPG study]5.7219354
GSM549128patient 025, cancer, homogenized [OPG study]9.460792
GSM549103patient 117, normal, homogenized [OPG study]7.6588979
GSM549117patient 073, normal, homogenized [OPG study]6.1091661
GSM549138patient 041, cancer, homogenized [OPG study]10.072794
GSM549141patient 045, cancer, homogenized [OPG study]9.2246990
GSM549130patient 028, cancer, homogenized [OPG study]5.6009552
GSM549101patient 111, normal, homogenized [OPG study]8.664487
GSM549105patient 128, normal, homogenized [OPG study]6.4789465
GSM549106patient 134, normal, homogenized [OPG study]9.9993793
GSM549112patient 048, normal, homogenized [OPG study]7.0639372
GSM549125patient 011, cancer, homogenized [OPG study]7.4253876
GSM549127patient 024, cancer, homogenized [OPG study]11.451498
GSM549135patient 035, cancer, homogenized [OPG study]9.0212788